期刊文献+

放疗分割剂量对食管癌细胞耐药基因表达的影响 被引量:1

Dose effect of radiotherapy on drug resistance in esophageal cancer cell
原文传递
导出
摘要 目的:观察不同放疗剂量对食管癌细胞EC9706耐药基因MDR1表达水平的影响,同时分析其对细胞化疗耐药性的作用。方法:对食管癌细胞分别按常规剂量组(2 Gy/d.f)和小剂量组(1 Gy/d.f)进行分次外照射,共20次。采用实时定量PCR(QRT-PCR)和Western blot对外照射前后处于缺氧培养下的食管癌细胞MDR1表达水平进行检测。MTT实验评估化疗细胞抑制率。结果:照射前缺氧培养下的食管癌细胞MDR1表达水平即较对照组明显升高(P<0.05)。接受20次2 Gy/d.f照射后食管癌细胞的MDR1表达水平明显高于单纯缺氧培养组(P<0.05),但小剂量照射组的MDR1表达则明显减低(P<0.05),同时其耐药指数亦明显下降(P<0.05)。结论:同缺氧条件下进行常规剂量分次外照射相比,小剂量分次外照射可以缓解食管癌细胞的耐药程度,推测其辅助化疗疗效应较好。 AIM:To investigate the dose effect of fractioned ionizing radiation on the expression of MDR1 in human esophageal cancer cells.METHODS:The mRNA and protein levels of MDR1 in esophageal caner cell line EC9706 incubated in culture containing 150 μmol/L CoCl2 pre-and post-irradiation were measured by quantitative reverse transcription-polymerase chain reaction(QRT-PCR) and Western blot analysis,respectively.The chemo-sensitivity was analyzed by MTT.RESULTS:Comparing with the control group,hypoxia culture significantly induced MDR1 expression(P〈0.05).After 20 fractions of irradiation,the MDR1 expression was significantly up-regulated in 2 Gy/d·f group(P〈0.05),while obviously decreased in 1 Gy/d·f group(P〈0.05).Consequently,the cell inhibitory rate was significantly reduced in 2 Gy/d·f group,but increased in 1 Gy/d·f group(P〈0.05).CONCLUSION:These results indicate that MDR1 is differentially modulated by different doses of fractionated radiation,which should be taken into account when combining radiotherapy chemotherapy for esophageal cancer patients.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2010年第2期152-153,156,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 陕西省卫生厅基金资助项目(08E06)
关键词 多药耐药基因 食管癌 放疗 化疗 MDRI esophageal cancer radiotherapy chemotherapy
  • 相关文献

参考文献8

  • 1Sagar PM, Sue-Ling H, McMahon MJ, et al. An audit of the treatment of cancer of the oesophagus [ J ]. Gut, 1994, 35 (7) : 941 - 945.
  • 2Okamoto K, Isamu O, Ken T, et al. Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients [ J ]. Jpn J Clin Oncol, 2009, doi: 10. 1093/jjco/hyp137.
  • 3Sambrook J, Fritsch EF, Maniatis T(金冬雁,黎孟枫,等译).分子克隆[M].2版.北京:科学出版社,1996:889-890.
  • 4Ana M, Sanchez JTB, Patricia VS. Fractionated ionizing radiation accelerates loss of amplified MDR1 genes harbored by extrachromosomal DNA in tumor cells[J]. Cancer Res, 1998, 58:3845 -3854.
  • 5Hill BT, Moran E, Etievant C, et al. ted X-irradiation of ovarian tumor cells cells overexpressing two multidrug Low-dose twice-daily fractionain vitro generates drug-resistant iated proteins, P glycoprotein and MRP[ J]. Anticancer Drugs, 2000, 11 (3) : 193 200.
  • 6Ng IO, Lam KY, Ng M, et al. Expression of P-glyeoprotein, a multidrug resistance gene product, is induced by radiotherapy in patients with oral squamous cell carcinoma[ J ]. Cancer, 1998, 83 (5) : 851 - 857.
  • 7Zhao KL, Shi XH, Jiang GL, et al. Late course accelerated hyperfrac- tionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study[J].Int J Radiat Oncol Biol Phys, 2005, 62(4) : 1014 -1020.
  • 8Roberts DL, Williams KJ, Cowen RL, et al. Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorcctal cancer cells[J]. Br J Cancer, 2009, 101 (8) : 1290 - 1297.

同被引文献15

  • 1胡礼仪,周新,张有顺,戴宗晴,黄玲,王菊.载体介导的RNA干扰技术抑制肝癌耐药细胞MDR1表达的研究[J].肿瘤防治杂志,2004,11(11):1158-1162. 被引量:8
  • 2秦维超,张有顺,周新,胡礼仪,黄玲.抑制MDR1基因表达shRNA RNAi系统的构建[J].山东医药,2005,45(13):19-20. 被引量:4
  • 3Yamaguchi-Iwa/Y, Sonoda E, Sasaki MS, et al. Mrell is essential for the maintenance of chromosomal DNA in vertebrate cells [ J ]. EMBO J, 1999, 18(23):6619-6629.
  • 4Liao S, Guay C, Toczylowski T, et al. Analysis of MRE11 function in the 5'-3' processing of DNA double-strand breaks [ J ]. Nucleic Acids Res, 2012, 40(10) : 4496 -4506.
  • 5Foster SS, Balestrini A, Petrini JH. Functional interplay of the MREll nuclease and Ku in the response to replication-associated DNA damage[J]. Mol Cell Biol, 2011, 31 (21) : 4379 -4389.
  • 6Li J, Li ZN, Du YJ, et al. Expresion of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival [ J]. Clin Lung Cancer, 2009, 10(6) : 414 -421.
  • 7j Arora S, Kothandapani A, Tillison K, et al. Downregulation of XPF- ERCC1 enhances cisplatin efficacy in cancer cells[ J]. DNA Repair (Amst), 2010, 9(7) : 745 -753.
  • 8Petrini JH. The Mrell complex and ATM: collaborating to navigate S phase[J]. Curr Opin Cell Biol, 2000, 12(3) : 293 -296.
  • 9Yoshihiko M, Hiroshi S, Masaru M. Molecular mechanisms of esophageal squamous cell carcinogenesis: clues to improve treatment outcomes[J]. Ann Thorac Cardiovasc Surg, 2010, 16(6) : 387 - 388.
  • 10Lee J, Dunphy WG. The Mrell-Rad50-Nbsl (MRN) complex has a specific role in the activation of Chkl in response to stalled replication forks [ J ]. Mol Biol Cell, 2013, 24 (9) : 1343 - 1353.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部